Denise Pollard-Knight

Affiliations

  • Chief Executive Officer at Mereo Biopharma Group Plc (MREO), 2024-01-26
  • at Elanco Animal Health Inc (ELAN), 2023-12-04
  • Director at Oncomed Pharmaceuticals Inc (OMED), 2018-06-25
  • Large Shareholder, Director at Albireo Pharma Inc. (ALBO), 2017-06-20
  • Director at Idenix Pharmaceuticals Inc (IDIX), 2014-08-05
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
OMED $17.00 58,824 Director 2,122,807 2013-07-23 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
OMED $21.66 3,799 Director 1,943,509 2014-12-31 Filing
OMED $21.65 5,510 Director 1,947,308 2014-12-30 Filing
OMED $21.62 9,902 Director 1,952,818 2014-12-29 Filing
OMED $21.65 2,195 Director 1,962,720 2014-12-26 Filing
OMED $21.71 20,654 Director 1,964,915 2014-12-19 Filing